Research
Drug-Eluting Stents versus Coated Stents in Diabetic Patients with Acute Coronary Syndrome
Author(s): Ahmed Alsherif, Mohamed Ashraf, Ayman Moharram, Mahmoud Khaled* and Ahmed Rostom
Background: The term Acute Coronary Syndrome (ACS) is a term that describes the acute phase of ischemic coronary artery disease whether myocardial cell necrosis happens or not. Objective: To compare coated stents and drug-eluting stents in terms of Major Adverse Cardiac Events (MACE) and Instent Restenosis (ISR) rate. Patients and methods: A prospective, comparative, controlled, single-center study was conducted on forty diabetic patients diagnosed as NSTE-ACS with TIMI risk score ≥ 3, whose coronary angiography showed de novo CAD with ≥ 70% luminal stenosis to assess the influence of coated stent on the incidence of MACE and ISR after PCI in comparison with Drug-Eluting Stents (DES) in high-risk patients with ACS. Patients were divided into 2 groups according to the type of the stent; coated stent (titan 2) for group (A) and DES (Xience) for the group (B). MACE was reported dur.. Read More»
Select your language of interest to view the total content in your interested language